QuVa Pharma recalls
QuVa Pharma has 38 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 15 Jul 2026. 5 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is particulate matter.
Total recalls38since 2016
Last 12 months2reported
Class I25% of total
Ongoing5latest 15 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 5%Class II 33 87%Class III 3 8%
Why quva pharma is recalled
Product types
By year
Ongoing quva pharma recalls
5 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methohexital Sodium, 100 mg/ (10 mg/mL), Total Volume recalled | QuVa Pharma | Potency & Assay | Nationwide |
| Drug | CLASS II | R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl recalled | QuVa Pharma | Particulate Matter | Nationwide |
| Drug | CLASS II | fentaNYL Citrate PF 200 mcg recalled by QuVa Pharma | QuVa Pharma | Sterility | Nationwide |
| Drug | CLASS II | fentaNYL Citrate PF 200 mcg recalled by QuVa Pharma | QuVa Pharma | Sterility | Nationwide |
| Drug | CLASS II | fentaNYL Citrate PF 200 mcg recalled by QuVa Pharma | QuVa Pharma | Sterility | Nationwide |
All quva pharma recalls, newest first
38 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.